EVOK EVOKE PHARMA INC Delisting Actions 8-K Filing 2023 - Non-Compliance Warning Evoke Pharma received a notice of non-compliance with minimum stockholders' equity requirements from Nasdaq, where its equity of $2.1 million was less than the $2.5 million required. Evoke has submitted a plan for regaining compliance and Nasdaq has given them an extension until November 20, 2023 to comply. If the plan fails, the company may face delisting from Nasdaq.Get access to all SEC 8-K filings of the EVOKE PHARMA INC